简体中文 | 繁體中文 | English

Health and Pharmaceutical Press Releases

2022-12-30 10:37 Biocytogen Launches RenNano™ Mouse, a Fully Human Heavy Chain Antibody Platform to Accelerate Nanobody Drug Discovery
2022-12-23 09:12 Merck Announces Collaboration with Mersana Therapeutics to Develop Novel Immunostimulatory Antibody-Drug Conjugates
2022-12-21 09:27 Boehringer Ingelheim announces appointments to Board of Managing Directors
2022-12-20 09:40 Boehringer Ingelheim and Click Therapeutics expand their existing Collaboration to develop Prescription Digital Therapeutics for Schizophrenia
2022-12-19 14:30 Biocytogen Announces FDA Clearance of IND Application for Bispecific Antibody YH008
2022-12-19 10:09 Aptorum Group Announces Completion of $3 Million Convertible Note due 2023
2022-12-16 17:55 Dermaliq Therapeutics Announces First Participant Randomized in Phase 1b/2 Trial Evaluating DLQ01 Solution for Treatment of Androgenic Alopecia
2022-12-16 13:11 Mori Memorial Foundation Issues GPCI-2022 & CPS-2022 Report
2022-12-16 09:48 Takeda to Acquire Late-Stage, Potential Best-in-Class, Oral Allosteric TYK2 Inhibitor NDI-034858 From Nimbus Therapeutics
2022-12-16 09:39 CAS Introducing Transformational Capabilities to Accelerate Life Sciences Innovation
2022-12-14 15:34 AOP Health presents latest updates on BESREMi® (Ropeginterferon alfa-2b) in Polycythaemia Vera at the American Society of Hematology (ASH) 2022 Annual Meeting
2022-12-14 15:25 Cancellation of remaining publicly held registered shares of Vifor Pharma AG
2022-12-14 09:43 European Commission approves SPEVIGO® (spesolimab) for generalized pustular psoriasis flares
2022-12-13 19:33 Reduced-risk* Potential of Velo as Cigarette Alternative Reinforced by Innovative Real-world Study
2022-12-13 19:30 Organon Appoints Kirke Weaver as General Counsel and Corporate Secretary
2022-12-13 19:25 Takeda to Present Data at 64th American Society of Hematology (ASH) Annual Meeting, Demonstrating Commitment to Patients with Hematologic Cancers and Other Blood Diseases
2022-12-13 16:55 MRM Health and IFF Reach Second Milestone in the Partnered Type 2 Diabetes Program
2022-12-13 15:29 Masimo Announces Limited Market Release of Sepsis Index
2022-12-13 14:38 Takeda’s QDENGA®▼ (Dengue Tetravalent Vaccine [Live, Attenuated]) Approved for Use in European Union
2022-12-13 09:47 IWBI Launches the WELL Equity Rating to Advance Organizations and Places Where “Everyone Feels Welcome, Seen and Heard”

Business Wire Weibo

Press Releases

Latest Releases